Transcript for Rare clotting risk with Johnson & Johnson vaccine
But doc, the news, my goodness, this vaccine, j&j big news. Big news today. But let's get the numbers on coronavirus from Johns Hopkins university, 136.6 million confirmed covid-19 cases worldwide, 562,000 American lives lost to this virus now and the number of vaccinations growing, CDC reporting more than 189.6 million doses adminstered across the country. But doc, vaccine news, j&j pause, what does this mean? So this is rapidly evolving story just broke this morning, and here's what we know at this point, the fda and the CDC are recommending a pause on the U.S. Johnson & Johnson vaccine rollout, have to keep in mind the numbers they've given almost 7 million doses of this vaccine in this country this year, so far only six cases of a rare blood clot in the brain associated also with low platelets. All of these have occurred in women ages 18 to 48. They've had one death. One of these women is in critically condition. I have to tell you, my daughter, my 18-year-old daughter got the j&j vaccine last week, someone like me, a parent who might be concerned, how do we interpret this news? I think it's really important again to remember the numbers, less that 1 in a million chance of this, it's extremely rare, it's not uncommon to see these safety signals then going on to pause a vaccine rollout. This is our system at work and just before we came on the air we've got news in Europe Johnson & Johnson is proactively delaying the rollout of this vaccine to err on the side of caution. No one is taking any chances. Could make people feel more at the same time, this is supposed to give us reassurance that the process is working. I think it's reassuring.
This transcript has been automatically generated and may not be 100% accurate.